CSC-012-ADC

N/A

Report date: 2025/05/14 15:49:57

Base Information

Drug NameCSC-012-ADC
Drug Alias NameCSC-012-ADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionInterleukin-1 receptor accessory protein inhibitors
TargetsInterleukin-1 receptor accessory protein
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellerant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellerant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A